KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Other financing activities (2016 - 2025)

Labcorp Holdings' Other financing activities history spans 13 years, with the latest figure at $8.9 million for Q4 2025.

  • For Q4 2025, Other financing activities fell 70.03% year-over-year to $8.9 million; the TTM value through Dec 2025 reached $13.5 million, changed N/A, while the annual FY2023 figure was -$19.6 million, 27.41% up from the prior year.
  • Other financing activities for Q4 2025 was $8.9 million at Labcorp Holdings, up from -$3.3 million in the prior quarter.
  • Across five years, Other financing activities topped out at $1.6 billion in Q2 2023 and bottomed at -$1.5 billion in Q4 2023.
  • The 4-year median for Other financing activities is -$4.0 million (2024), against an average of -$4.1 million.
  • The largest annual shift saw Other financing activities tumbled 5527.04% in 2023 before it surged 101.95% in 2024.
  • A 4-year view of Other financing activities shows it stood at -$27.0 million in 2022, then crashed by 5527.04% to -$1.5 billion in 2023, then soared by 101.95% to $29.7 million in 2024, then crashed by 70.03% to $8.9 million in 2025.
  • Per Business Quant, the three most recent readings for LH's Other financing activities are $8.9 million (Q4 2025), -$3.3 million (Q1 2025), and $29.7 million (Q4 2024).